DOYLESTOWN, Pa., Feb. 28, 2018 -- Alamo Pharma Services (“Alamo”) was recently recognized as one of Training magazine’s annual Training Top 125, that ranks companies’ excellence in employer-sponsored training and development programs. The rankings were unveiled during an awards gala held in conjunction with the recent Training 2018 Conference and Expo in Atlanta.
“Receiving this recognition from Training magazine, a true ‘go-to resource’ for all industries, is an exciting honor for the team at Alamo,” says Peter Marchesini, Chief Operating Officer of Alamo. “We’re tremendously proud of our training programs. It is gratifying to be saluted as one of the top training organizations in the country along with all of the other deserving winners.”
Training magazine, the leading business publication for Learning and Development professionals, has been releasing its Training Top 125 rankings for the past 18 years. The results are determined by assessing a range of qualitative and quantitative factors and benchmarking statistics including:
- Total training budget
- Percentage of payroll
- Number of training hours per employee program
- Goals, evaluation, measurement, and workplace surveys
- Hours of training per employee annually
- Detailed formal programs
“We salute the 2018 Training Top 125 winners’ fierce commitment to employee learning and development and their passionate belief that training matters,” says Lorri Freifeld, editor-in-chief of Training magazine. “These companies constantly look for innovative ways to effectively deliver and measure employee training, and they are rewarded with an engaged, passionate workforce and organizational success.”
About Alamo Pharma Services
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit www.AlamoPharmaServices.com or email [email protected].
Alamo is part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created by Mission Pharmacal to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit www.missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c799dcc2-28a9-4a5a-ba31-c243ea60be8b
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0e77db05-7e11-4d68-a090-55e47903fdab
Drew Deeter DeeterUSA 215.348.3890 [email protected]


Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
OpenAI Restricts Astra AI Over Cyberattack Risks
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 



